Sunday 7 April 2024

A Profitable IPO With Major Upside

 

Massimo Group (MAMO) is a new IPO that went live last week. It raised just under $6 million by issuing 1.3 million shares at $4.5 million. The IPO crashed out of the gate on heavy volume, but has been rising back up since on light volume. If you're looking for a big runner, this is the type of volume profile you want to see leading up into it. Rising price on low volume:







MAMO has the makings of the next IPO runner. It's fundamentally worth far more than $4.00 while also having the potential of running like other legendary small float Asian-related IPOs like HKD, MEGL, UCAR, ATXG and dozens more that spiked to $10+ and sometimes even $100+ or $1,000+ out of the gate before eventually tanking. What makes MAMO different is that it's actually profitable, growing fast and is very undervalued at its current market cap. It had $10.4 million in net income in 2023, leading to a $0.26 EPS. That's a 15 P/E at $4.00, but that doesn't tell the full story. Revenue growth was 33% on the year. That growth as well as growth in the EPS was heavily weighted towards the back of the year. That means 2024 should see far higher revenue and EPS figures than 2023. 

What also makes MAMO stand out is that while it's "Chinese-related", it's really an American company. CEO David Sham has lived in the United States since 1995, immigrating from China back then. While some manufacturing takes place in China (no different than most companies), the main operations are in Texas. This is an American company with ties to China as opposed to a Chinese company with a confusing VIE structure. 

There are 41.3 million shares outstanding, but 34 million of those belong to the CEO with another 6 million owned by a seed investor called ATIFUS. That leaves only the shares in the capital raise as part of the float. With volume drying up, all it would need is a catalyst to spark an explosion upward in price. We think that explosion will be the next financial update. 

ATIF's association with MAMO leads to another important point in favor of MAMO going on a massive run. ATIF played a significant role in NCL and GMM going public. Both of those stocks rose from $5.00 to $15 or more within three weeks of listing. So they clearly know how to push a stock strong out of the gate. 

This is the price history of GMM shortly after it listed. Notice how leading up to its run from $5 to $15, it ran up on low and dissipating volume before picking up again at the high. Very similar to what we have seen on MAMO so far:












NCL tells much the same story. In fact its story is even more similar to MAMO as it initially tanked out of the gate then started to rise back up on only 100,000 or so of daily volume. The first four days of NCL's trading is very similar to MAMO's first four days:













If you like our picks you can follow this blog by clicking the follow button on the top of the left hand panel. We have 1016 followers on here as well as 122 followers on our Canadian blog. You can also follow us on Twitter @StockTradePicks which has over 5,000 followers.


Disclosure: We are long MAMO


Wednesday 13 March 2024

CLRO $0.50 Dividend Should Lead It To A MEDS-Like Run

Last Wednesday we announced a trade alert on TRxADE HEALTH, Inc. (MEDS) when it was trading at $11.50 after it announced an $8 dividend. The stock has risen to over $33 as it nears the dividend payout date. We expect the same thing to happen on ClearOne, Inc. (CLRO) which announced a $0.50 dividend yesterday. The dividend is payable to record holders on April 2, so we expect the stock price to steadily rise for the next 2-3 weeks heading into that date just like it has done for MEDS. 

At the time we sent out the trade alert on MEDS, it was trading below its book value and net cash. Now at over $33, it is trading at over a $40 million market cap, significantly above its book value. At yesterday's $2.06 closing price, CLRO is currently trading at a $49 million market cap. This is slightly above its book value of $42 million while its working capital sits at $35 million. However, the difference between MEDS and CLRO is that while MEDS is near shell status, CLRO's operations continue onwards. The CEO stated in the press release that the company has an achievable plan to return to revenue growth and profitability. As the company has a net loss of about $1 million per quarter for the first nine months of last year, we think that this statement is achievable. 

Last May CLRO announced a $1.00 special dividend. The stock rose to a little over $2.50 on that run before it obviously tanked after the dividend was paid. However, that announcement occurred when the market was a lot more shaky. Based on how MEDS has traded in the past week and how it went from trading at a discount to its net cash to nearly a 100% premium, we think that CLRO can have a similar run to $5.00.

If you like our picks you can follow this blog by clicking the follow button on the top of the left hand panel. We have 1016 followers on here as well as 122 followers on our Canadian blog. You can also follow us on Twitter @StockTradePicks which has over 5,000 followers.

Wednesday 6 March 2024

MEDS: $8 Per Share Cash Dividend Leads To Strong Upside With Minimal Downside

This is a trade alert on TRxADE HEALTH, Inc. (MEDS). It's up 38% today to around $11.50 in mid-morning trading on the announcement of a special cash dividend of $8 per share. This huge news means that the floor is $8.00 but the upside is much more than that. This distribution was made possible because the company sold its web-based market platform for $22.5 million. This deal comes with a clause that could see an additional $7.5 million payment, for up to $30 million. MEDS has $5.2 million in notes payable. Net of this amount, the market cap should be at least $17.3 million or about $14.30 per share with only 1.2 million shares outstanding. If the $7.5 million payment comes to fruition, that net cash value increases to $20.50. With a float of only 452,000, this is one of those rare opportunities where a retail trader can trade a low float stock with a guaranteed floor and no chance of a rug-pull financing.

At around $11.50, there is only $3.50 of downside possible but the upside is technically unlimited in a squeeze situation with that kind of float. Post-distribution, it's unlikely that the stock will drop and stay at $3.50 as it will still be trading well below net cash value and have some operations remaining. This looks like a trading opportunity with strong risk-to-reward imbalance to the upside. A rarity in a stock with such a small float.

If you like our picks you can follow this blog by clicking the follow button on the top of the left hand panel. We have 1017 followers on here as well as 122 followers on our Canadian blog. You can also follow us on Twitter @StockTradePicks which has over 5,000 followers.

Sunday 30 July 2023

Sintana Energy: Small Cap Namibian Offshore Oil Play With Massive Speculative Upside

Last month we posted on our Canadian blog about Sintana Energy Inc. (SEI.V) (SEUSF). After a few weeks of trading on the TSX Venture in the $0.25-$0.30 range, it has finally broken out to new 52-week highs this past week, closing at $0.33 CAD on Friday. We think this breakout is just the beginning as Sintana represents a unique ground floor opportunity to get into a pureplay on the Orange Basin in Namibia at less than $100 million market cap. What's more is that there is a cheap leveraged opportunity on in-the-money warrants which could move up 10 times if the stock price triples. If you like our picks you can follow this blog by clicking the follow button on the top of the left hand panel. We have 1018 followers on here as well as 119 followers on our Canadian blog. You can also follow us on Twitter @StockTradePicks which has over 5,000 followers.

Sintana has oil interests in Colombia, but by far the most prospective opportunity is its multiple onshore and offshore holdings in and around the Orange Basin in Namibia. Two multi-billion barrel discoveries were made last year in the basin, but it was the third discovery announced in March by state-owned NAMCOR and its partners Shell and QatarEnergy that appeared to be the catalyst for Sintana's recent rise in stock price as its potentially the biggest discovery to date.


















Reviewing the company's corporate presentation, you get a good sense of where its interests lie relative to these three discoveries. Jonker-1X sits between Graff-1X and Venus-1X, even closer to PEL-83 and PEL-90:


Both are carried by larger players with drilling expected in 2023. However, given how Sintana reacted since the announcement of the Jonker-1X find, it doesn't even need news on its own interests to continue its run. Another discovery made in the region will almost certainly lift the stock price. This may be why the company is Tweeting out news about TotalEnergies SE (TTE) being days away from carrying out the first production test on Venus amid hints that the thickness of hydrocarbon pay zones may be bigger than revealed originally. This anticipation is what is causing Sintana's continued breakout. TTE has a $145 billion market cap. A major discovery well beyond initial expectations is only going to move the stock a few percentages points. A 10% move is $15 billion addition to the market cap. Sintana on the other hand could add $100 million in market cap as a neighboring interest and more than double its stock price. 

This is where the warrants come in. They have a strike price of $0.25 and expire next March. As the stock closed at $0.33 on Friday, they are worth $0.08 but last traded at $0.075, so there is no time value attached to them. This makes them extremely cheap upside leverage for anyone who is willing to tolerate a risk of a complete loss if the stock is $0.25 or less by March. This chart summarizes the opportunity:







If the stock drops to $0.25 or less by next March, the warrants are worthless. But if an owner of the warrants decides to sell their warrants before expiry, they are likely to recover something from them even if the stock price drops below $0.25. At $0.30, or a 9% loss on the stock, the warrants are worth $0.05, or a 33% loss. However, the stock only needs to rise 6% to $0.35 to have the warrants increase 33% in intrinsic value to $0.10. At $0.40, the value of the warrants doubles to $0.15. The leveraged upside becomes apparent until the stock triples to $1.00, where the warrants would be worth $0.75. A 900% increase or 10 times your money from $0.075. We think that these warrants are an absolute steal with no time value as news and hype around the Orange Basin isn't going to stop any time soon.  

Edit August 1: Galp Energia, SGPS, S.A. (GLPEY) has identified large and high quality prospects on PEL 83. Sintana owns a 4.9% stake through its 49% ownership in Custos Energy. Once official news is released on this discovery, we expect Sintana to skyrocket. 

Disclosure: We are long SEI.WT. 



Wednesday 12 April 2023

SCLX: One Step Closer to that Major Short Squeeze

Edit 4/13: This morning the stock price fell to less than $11.00 in pre-market activity. SCLX has since returned to the $14's within the first 10 minutes of regular hour trading, indicating desperation tactics by shorts that are failing. In our opinion, we are on the brink of that squeeze.

On Friday, we published a bullish report on Scilex Holding Company (SCLX) called "SCLX Might be the Short Squeeze Meme Traders Have Been Waiting For". Since then the stock has continued to steadily rise, closing at $14.80 today. This is despite an S-1 filing for the release of 3.3 million shares for an $8.00 convertible debenture. We think this activity is getting the stock one step closer to the short squeeze that meme traders and other supporters of the stock are looking for as we close in on the April 17th Annual Meeting of Stockholders. If you like our picks you can follow this blog by clicking the follow button on the top of the left hand panel. We have 1019 followers on here as well as 120 followers on our Canadian blog. You can also follow us on Twitter @StockTradePicks which has over 5,000 followers.

Before getting into our update, first we will repeat the short squeeze theory. SCLX was a spinout of Sorrento Therapeutics, Inc. (SRNEQ), a polarizing and heavily-shorted company that has had many ups and downs through its trading history. Sorrento somewhat voluntarily went through the bankruptcy process post-spinout, presumably in an attempt to get a court-order account of the shares in SCLX. It might be working. This article provides a brief history of the situation between SRNEQ and SCLX, as well as the theory behind the short squeeze. While SCLX's float on Yahoo Finance is reported to be 85 million, that actually isn't true. The vast majority of these shares are locked up until May 11, with the actual float being in the two million range. There is another six million or so warrants (SCLXW) with a strike price of $11.50, but over a million of those have been purchased by Sorrento on the open market. 

At the time of the spinout, there were around 60 million shares short of SRNE. This translated to 8.5 million SCLX shares short, all of which have the same lockup restrictions as the long shares, except that cost to borrow and margin requirements still apply. There aren't enough shares and warrants currently in the market to allow shorts to hedge. If brokers force the closure and margin calls of these positions before the May 11th hold period expires, the owners of the tradeable stock and warrants hold all the cards. They can set the price at which they want to sell. This of course only applies to reported shorts. It doesn't account for naked shorts, which if you believe the meme stock narrative, would be multiples higher of reported short interest.

Sorrento and Scilex are working hard to account for and stimulate the need to close off the short positions. As part of the bankruptcy proceedings, the companies got a court order for the top 25 brokers in the United States to provide a full ownership report of SCLX shares to Sorrento. Out of the 76 million shares issues, so far 44 million have not been reported. SCLX delayed its AGM from April 6th to 17th in order to give time for the brokers to account for the discrepancy. 

One blogger speculates that this has been an intricate plan by Sorrento to force the covering of shorts. Sorrento having purchased some SCLXW warrants on the open market in addition to the massive SCLX holding it has could be a sign that the company is trying to profit from a short squeeze as well as exacerbate the situation for the shorts by reducing the availability of SCLX securities on the open market. 

The preliminary S-1 filed after hours on April 10th involves the release of 3.3 million shares upon conversion of a $25 million debenture at $8.00. This would alleviate, but not completely eliminate, the problem for the unreported naked shorts. This is an opportunity for the debenture holder like it is for anyone who holds free trading stock. They are not required to convert the debentures into stock immediately and the longer they wait, the more interest they collect (which can also be converted into more stock). Bears on the stock were immediately shouting from the rooftops about this filing and coming dilution, and the stock did drop 8% from $14.15 to $13.00 the next day. But that drop was short lived as it was followed up with a 14% rise to $14.80 today. No doubt that this is continued covering or hedging by shorts, as well as opening of long positions by people who believe in this massive short squeeze opportunity. 

The $14.80 price seen today is the highest the stock has closed. Not only is that a bullish sign in terms of technical trading, it also means the mark-to-market price that helps to determine margin requirements on short positions is higher than it has ever been. No matter what happens on May 11th when the lock comes off the distributed shares, or with the debentures, or the long term success of the company, the only thing that is relevant from a broker's risk management and credit department is the value of the short position today. Not what it might be 28 days from now. Those 8.5 million shares short are now marked at a combined $125 million. When the stock was trading at $12.90 last week, those short positions were marked at $109 million. Keep in mind this short position was created out of a 60 million SRNE short position which at $1.83 on November 11 was worth $110 million. Now the spinout shares are getting marked at a higher value all by themselves, exclusive of the market value of the SRNEQ short position. It's not hard to calculate what the combined mark-to-market value of these short positions would be at $20 or $50 or $100 stock price. 

Meme traders should be able to smell the blood in this situation. The short position is getting more expensive to handle, and there is a larger short position than available float. Another clue to look at is the price of the warrants, SCLXW, relative to the stock. The warrants have a strike price of $11.50. Therefore they should trade at $11.50 less than the stock price, plus some time premium just like all options do. The warrants have generally traded with at least a $1.00 time premium. For instance, when the stock closed at $13.00 yesterday, the warrants closed at $3.10. $13.00 less $11.50 would lead to a $1.50 intrinsic value with the remaining $1.60 being attributed to time value. Today the warrants closed at $3.51 with the stock closing at $14.80, or $3.30 above the $11.50 strike price. That time premium has been almost completely eroded to $0.21. What does this mean? Shorts are losing control of the stock price. 

Think of every single SPAC that went absolutely haywire. Whether a very popular and liquid one like DWAC or a more obscure recent example like LUNR. When they raced to close to $100, the warrants were actually worth a lot less than their intrinsic value. DWACW was something like $50 or $60 while LUNRW topped out in the $2's. Even call options on these types of SPAC runners would trade with very little time value. People would try to take advantage of the "arbitrage" by going long warrants and writing call options and they would get assigned from the calls right away, forcing an open short position that they would have to cover or pay high CTB rate. Here's an article from 2020 explaining the scenario on NKLA back when it was a recent de-SPAC. Reading the comment section you will get the point of the weakness of this "arbitrage" play and why it actually stimulates a further short squeeze at the expense of someone who tried to do some creative but short sighted financial engineering: 



Unlike those other SPACs at the time of their big moves, SCLXW is exercisable so it won't ever trade far below its intrinsic value like LUNRW did. But it might trade a few percent below it for two reasons. First, SCLXW is less liquid than SCLX*, so there could be a point in time where the stock shoots up $0.50 but the warrants don't immediately follow simply for the fact that no bids or asks exist at that price. The second reason gets more to the point of shorter desperation, similar to the SPAC shorts and assigned call options mentioned above, except in reverse because these warrants are exercisable. SCLXW would trade less than their intrinsic value to entice warrant holders to exercise them rather than sell them on the open market and trade them back and forth between other bullish warrant holders like ourselves. Exercising the warrants increases the float of SCLX, which is exactly what SCLX shorts want in order to alleviate a further squeeze.  If SCLX gets to the point where SCLXW is trading at a greater variance than $11.50, the shorts are losing control of the situation. Yes they can buy the warrants to try to hedge their shorts and cap their margin requirements to the $11.50 strike price (plus cost of warrants), but if margin requirements put so much stress on a short's account that their broker doesn't allow financial engineering, it's near the breaking point. The position would need to be covered or hedged directly with stock, not with warrants. 

*The point about SCLXW being less liquid than SCLX is kind of funny given that there are actually three times MORE warrants than stock out in the open float right now. Common sense should be that warrants in the $3's with three times more float would trade with tighter spreads and with more volume than the stock in the $14's, but they don't. If there was ever any evidence of naked shorts rampant in the market, we would think this would be a clear example of it. 

We have bought the SCLXW warrants. Why the warrants? Simple, a bullish bet with the maximum upside potential. If the stock goes to $20 - a 35% increase from $14.80 - the warrants are worth at least $8.50 - a 142% increase from $3.51. 

Disclosure: We are long SCLXW

Friday 7 April 2023

SCLX Might be the Short Squeeze Meme Traders Have Been Waiting For

Over the last few years, retail traders who refer to themselves as apes have been targeting various "meme" stocks with high short interest such as GameStop Corp. (GME), AMC Entertainment Holdings, Inc. (AMC) and Bed Bath & Beyond Inc. (BBBY) in an effort to create a short squeeze. They have had varying degrees of success, though these stocks have pulled back significantly from their 2021 highs. Attempts to change the system have largely failed, though meme stock traders did manage to collapse one multi-billion dollar hedge fund in Melvin Capital. Scilex Holding Company (SCLX) is the latest meme stock gaining some traction, and in our opinion this unique situation has the best chance of creating a massive short squeeze over the next month. If you like our picks you can follow this blog by clicking the follow button on the top of the left hand panel. We have 1014 followers on here as well as 120 followers on our Canadian blog. You can also follow us on Twitter @StockTradePicks which has over 5,000 followers.

SCLX was a spinout of Sorrento Therapeutics, Inc. (SRNEQ), a polarizing and heavily-shorted company that has had many ups and downs through its trading history. Sorrento somewhat voluntarily went through the bankruptcy process post-spinout, presumably in an attempt to get a court-order account of the shares in SCLX. It might be working. This article provides a brief history of the situation between SRNEQ and SCLX, as well as the theory behind the short squeeze. While SCLX's float on Yahoo Finance is reported to be 85 million, that actually isn't true. The vast majority of these shares are locked up until May 11, with the actual float being in the two million range. There is another six million or so warrants (SCLXW) with a strike price of $11.50, but over a million of those have been purchased by Sorrento on the open market. 

At the time of the spinout, there were around 60 million shares short of SRNE. This translated to 8.5 million SCLX shares short, all of which have the same lockup restrictions as the long shares, except that cost to borrow and margin requirements still apply. There aren't enough shares and warrants currently in the market to allow shorts to hedge. If brokers force the closure and margin calls of these positions before the May 11 hold period, the owners of the tradeable stock and warrants hold all the cards. They can set the price at which they want to sell. This of course only applies to reported shorts. It doesn't account for naked shorts, which if you believe the meme stock narrative, would be multiples higher of reported short interest.

Sorrento and Scilex are working hard to account for and stimulate the need to close off the short positions. As part of the bankruptcy proceedings, the companies got a court order for the top 25 brokers in the United States to provide a full ownership report of SCLX shares to Sorrento. Out of the 76 million shares issues, so far 44 million have not been reported. SCLX delayed its AGM from April 6th to 17th in order to give time for the brokers to account for the discrepancy. 

One blogger speculates that this has been an intricate plan by Sorrento to force the covering of shorts. Sorrento having purchased some SCLXW warrants on the open market in addition to the massive SCLX holding it has could be a sign that the company is trying to profit from a short squeeze as well as exacerbate the situation for the shorts by reducing the availability of SCLX securities on the open market. 

The trading this past week has indicated that this is starting to work. SCLX usually trades a little over 100,000 shares in a day. But on Wednesday it traded nearly 12 million shares and shot up 57% from $7.92 to $12.40 while hitting a high of $16.90. That was followed up by a 4% increase on Thursday to $12.90 on 3.4 million shares. The stock opened at $10.20 but rose throughout the afternoon. That looked like typical naked short selling tactics to hit stop losses then cover throughout the day. No doubt that some shares have been purchased to hedge any restricted short position, while others are being flipped multiple times a day. But as we have already discussed, the free floating securities are less than the actual short position and potentially way less than any unreported naked short position. There may be unlimited demand from shorts needing to hedge their position. Especially if the price keeps going up and brokers increase margin requirements or force margin calls. 

This is sort of like the Meta Materials Inc. (MMAT) and MMTLP situation, except brokers can't merely settle any outstanding SCLX short position at closing value like they did with MMTLP. These shares are going in the opposite direction of MMTLP, from restricted or private hands into the public market. There is also a court order demanding reporting of any shareholder ownership, of which any excess beyond the 76 million would be implied to be borrowed or synthetically made in order to short. No matter how hard retail traders tried to make other stocks pop off, they never managed to get a court order demanding the accounting of all shares quite like this. This is unchartered territory for the short squeeze thesis. 

We have bought the SCLXW warrants. Why the warrants? Simple, a bullish bet with the maximum upside potential. If the stock goes to $20 - a 55% increase from Thursday's close - the warrants are worth at least $8.50 - a 232% increase from Thursday's close. 

Disclosure: We are long SCLXW

Wednesday 22 February 2023

UUU: Profitable Microcap Stock With 4x Upside and Short Squeeze Potential



Most stocks with floats of less than 5 million get there because of a reverse split. They might have ultra-small floats at the moment, but that won't last long as dilution is expected to come soon. That's what makes Universal Security Instruments, Inc. (UUU) a particularly rare gem. UUU has had 2.3 million shares outstanding for over a decade. The company doesn't dilute, but up until now it didn't make much money either. So it mostly stayed in the $2 to $10 range over the last 10 years, seldom trading most days with occasional volume spikes. However, after UUU's Q3 results last week, this stock has changed from range-bound small cap to undervalued gem with excellent potential for a short squeeze. If you like our picks you can follow this blog by clicking the follow button on the top of the left hand panel. We have 1014 followers on here as well as 119 followers on our Canadian blog. You can also follow us on Twitter @StockTradePicks which has over 5,000 followers.

From last week's press release:

OWINGS MILLS, Md.Feb. 16, 2023 /PRNewswire/ -- Universal Security Instruments, Inc. (NYSE AMEX: UUU) today announced results for its fiscal third quarter and nine months ended December 31, 2022.

For the three months ended December 31, 2022, sales increased approximately 8.3% to $5,758,661 compared to sales of $5,319,014 for the same period last year.   The Company reported net income of $341,312, or $0.15 per basic and diluted share, compared to net income of $35,351 or $0.02 per basic and diluted share for the same period last year.

For the nine months ended December 31, 2022, sales increased approximately 6.5% to $16,251,106 versus $15,259,235 for the same period last year.  The Company reported net income of $435,776, or $0.19 per basic and diluted share, compared to net income of $157,688 or $0.07, per basic and diluted share for the corresponding 2021 period.

"The primary reasons for the sales increases during the three and nine-month periods ended December 31, 2022, were improvements in deliveries from China and less port congestion in Long Beach, California. The primary reasons for the increases in net income during the three and nine-month periods were lower selling, freight, advertising and professional expenses, partially offset by the higher cost of electrical components due to continuing supply chain issues." said Harvey Grossblatt - President and CEO.

UUU earned $0.15 per share in Q3. While the rest of the world experiences inflation, UUU has gotten costs under control while still showing a benefit on the revenue side, with solid 8% revenue growth on the quarter. That resulted in a near ten-fold improvement in net income from $35,000 in the previous year's Q3 to $340,000. The $0.15 EPS for Q3 would lead to an annualized result of $0.60.  A P/E of 20 would justify a $12 stock price while the stock is trading at less than 5 P/E right now. While it's difficult to stretch out one quarter's result over a full year, it's clear from the steadily improving financials that the company is trending in the right direction. It could just as easily surpass a $0.60 EPS for the next four quarters as it could come short of the mark. 

The strong net income performance has also resulted in positive operating cash flow, allowing the company to pay off substantial debts and liabilities throughout the year. This will only increase profitability as interest expense will start to decline. 

We would like to being attention to the stock's trading since the Q3 results were released on Thursday afternoon. The stock hit a high of $3.64 on Friday, but was pushed down heavily in the afternoon to close at $2.48, up a mere 13% even with these outstanding results. Checking the Naked Short Report, there was 2.3 million in short marked volume on Friday. This is greater than the float. Combine that with total trading of 17 million on the day - 10x the float - it's clear that there was a lot of high frequency bot trading that day, as well as naked short selling. The algorithm was set up to short the stock, because traditionally the stock tanks after a run. This scares away retail traders until the next pump. 

The problem with this strategy is that this time around, the company's spike upward was justified on very strong financial results. With good earnings and a strong balance sheet, the company has the ability to pay a dividend or buy back shares. Both of these would cause large problems for the shorts and entice longs to buy in. With such a small float and low valuation, this stock can easily spike large on a squeeze. 

We have already seen the beginnings of a permanent turnaround in the price. After a weak open on Tuesday, it closed up 7% on the day. It then followed that up with an 11% increase on Wednesday. It busted through its 50-day MA and is set to challenge its 200-day MA once again after the pullback from its highs on Friday. If it breaks through it again, we think it can go on a major run on a short squeeze as it heads towards a stock price reflecting its fundamental value. 



Disclosure: We are long UUU